Mehdi Jorfi, Joseph Park, Rudy Tanzi, | 2021

Development of a Multicellular Brain Model to Study Brain-Vascular-Peripheral Immune Cells Crosstalk in Alzheimer’s Disease

Steven L. Wagner, | 2021

Continuing Studies of the Effects of GSM 776890 Administration on Amyloid Species and Microgliosis in Older Alzheimer’s Model Mice

Raja Bhattacharyya, Rudy Tanzi, | 2021

Effects of Depalmitoylation and ACAT Inhibition on Axonal Amyloid Beta Generation Via MAM-Associated palAPP

Deepak Kumar Vijaya Kumar, Nanda Kumar Navalpur Shanmugam, Rudy Tanzi, William Eimer, | 2020

Characterizing Gut Microbiome Synergy With Emphasis on Mycobiome and Its Impact on Alzheimer’s Disease (AD) Pathology in AD Mouse Models

Steven L. Wagner, | 2020

Comprehensive Analyses of Chronic Efficacy Studies with GSM 776890 for Submission of the Pre-IND Brochure to the FDA Prior to Pre-IND Meeting and IND Filing for the SAD/MAD Phase I Safety/Toxicity and Ultimately for Phase II and Phase III Efficacy Clinical Trials to Support the NDA

Nanda Kumar Navalpur Shanmugam, Deepak Kumar Vijaya Kumar, Rudy Tanzi, William Eimer, | 2020

Microbes and Alzheimer’s Disease: Metagenomics on Saliva, Cerebrospinal Fluid, Blood and Brain

Ali Ezzati, Richard Lipton, | 2020

Application of Machine Learning Methods in Alzheimer’s Disease Clinical Trials

William Eimer, Deepak Kumar Vijaya Kumar, Rudy Tanzi, | 2019

Tau and Amyloid Beta are Innate Immune Antimicrobial Peptides in the Brain